Close Menu
Journal of Pharmacology and Pharmacotherapeutics
    Browse
    • Home
    • Browse Issues
      • In Press
      • Current Issue
      • Past Issues
    • About
      • About Journal
      • Editorial Board
      • Bibliographic Listings
    • For Authors
      • Submission Guidelines
      • Submit Article
    • Contact
    Facebook X (Twitter) Instagram
    Journal of Pharmacology and PharmacotherapeuticsJournal of Pharmacology and Pharmacotherapeutics
    • Journal Homepage (SAGE)
    • Submission Guidelines
    Facebook X (Twitter) Instagram
    Submit
    • Home
    • Browse Issues
      • In Press
      • Current Issue
      • Past Issues
    • About
      • About Journal
      • Editorial Board
      • Bibliographic Listings
    • For Authors
      • Submission Guidelines
      • Submit Article
    • Contact
    Journal of Pharmacology and Pharmacotherapeutics
    Home»Volume 16, Issue 2»WITHDRAWAL – Administrative Duplicate Publication: ML-powered Internet of Medical Things Structure for Heart Disease Prediction
    Volume 16, Issue 2

    WITHDRAWAL – Administrative Duplicate Publication: ML-powered Internet of Medical Things Structure for Heart Disease Prediction

    February 18, 2025Updated:October 10, 20251 Min Read
    Share
    Facebook Twitter Email
    Mulani AO, Liyakat KKS, Warade NS, et al. ML-powered internet of medical things structure for heart disease prediction. Journal of Pharmacology and Pharmacotherapeutics 2025;0(0).
    DOI:10.1177/0976500X241306184
    Ahead of Print article withdrawn by publisher.
    Due to an administrative error, this article was accidentally published twice Online First with different DOIs. There was no duplication of the article in a printed version.
    The correct and citable version of the article remains:

    References

    Mulani AO, Sardey MP, Kinage K, Salunkhe SS, Fegade T, Fegade PG. ML-powered internet of medical things (MLIoMT) structure for heart disease prediction. Journal of Pharmacology and Pharmacotherapeutics. 2024;0(0). DOI:10.1177/0976500X241281490
    Erratum
    Previous ArticleExploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and Its Mutated Variants: Challenges and Future Directions
    Next Article Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and Its Mutated Variants: Challenges and Future Directions

    Related Articles

    Comparison and Estimation of Salivary sTREM-1 and IL-1β in Periodontitis and Diabetes Mellitus Patients before and after Non-surgical Periodontal Therapy using Hyaluronic Acid and Diode LASER: A Clinical Trial

    Volume 16, Issue 2

    An Observational Study on Prescription Patterns of Drugs and Psychiatric Disorders Occurring in Child and Adolescent Patients in a Tertiary Care Hospital

    Volume 16, Issue 2

    Clinical Characteristics and Risk Factors for Persistent Thrombocytopenia among Pediatric Patients after Bone Marrow Transplant in Saudi Arabia: A 3-Year Retrospective Observational Analysis from Tertiary Hospital

    Volume 16, Issue 2
    Read Now
    Uncategorized

    Suzetrigine: A First-in-class NaV1.8 Inhibitor for Opioid-free Pain Management

    January 19, 2026

    Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundOpioids have been an integral part of…

    Cardiotoxicity Induced by Doxorubicin: Exploring Research Frontiers, Co-word Analysis, Trends, and Thematic Development

    January 15, 2026

    A Comparative Study on the Effect of Placebo and Oral Clonidine as a Premedication on Onset and on the Duration of Spinal Anaesthesia with Hyperbaric Bupivacaine

    January 12, 2026
    Editor picks

    WITHDRAWN – Administrative Duplicate Publication: ML-powered Internet of Medical Things Structure for Heart Disease Prediction

    February 18, 2025

    Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and Its Mutated Variants: Challenges and Future Directions

    February 18, 2025

    Low Back Pain Management Through Bowel Lavage (Panchaprasrutik Basti)—A Single Arm Clinical Trial

    February 18, 2025
    About Journal
    About Journal

    The Journal of Pharmacology and Pharmacotherapeutics (JPP) is an open access, peer-reviewed journal that publishes high-quality articles pertaining to basic research and clinical studies in the domains of Pharmacology and Pharmacotherapeutics.

    We're accepting new partnerships right now.

    Email Us: editor.jpp@phcog.net

    Facebook X (Twitter) RSS
    Our Picks

    WITHDRAWN – Administrative Duplicate Publication: ML-powered Internet of Medical Things Structure for Heart Disease Prediction

    February 18, 2025

    Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and Its Mutated Variants: Challenges and Future Directions

    February 18, 2025

    Low Back Pain Management Through Bowel Lavage (Panchaprasrutik Basti)—A Single Arm Clinical Trial

    February 18, 2025
    Stay Connected

    Contact Editor-In-Chief
    Editor, Journal of Pharmacology and Pharmacotherapeutics
    Manuscript TechnoMedia LLP,
    #9, Vinnse Tower, Wheeler Road Extn.
    St. Thomas Town, 560084, Bangalore, INDIA
    Email: editor.jpp@phcog.net


    • Home
    • Site Map
    © 2026 JPharmacol.com Designed & Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.